Weijian Liu

W. Liu, J. Heij, S. Liu, L. Liebrand, M. Caan, W. van der Zwaag, D. J. Veltman, L. Lu, M. Aghajani, G. van Wingen, Structural connectivity of thalamic subnuclei in major depressive disorder: An ultra-high resolution diffusion MRI study at 7-Tesla. J. Affect. Disord. 370, 412–426 (2025).

Y. Han, Y. Gao, S. Wang, X. Lin, P. Li, W. Liu, L. Lu, C. Wang, Cortical folding in distinguishing first-episode bipolar and unipolar depression. J. Affect. Disord. 369, 897–905 (2025).

W. Liu, J. Heij, S. Liu, L. Liebrand, M. Caan, W. van der Zwaag, D. J. Veltman, L. Lu, M. Aghajani, G. van Wingen, Structural connectivity of dopaminergic pathways in major depressive disorder: An ultra-high resolution 7-Tesla diffusion MRI study. Eur. Neuropsychopharmacol. 89, 58–70 (2024).

W. Liu, J. Heij, S. Liu, L. Liebrand, M. Caan, W. van der Zwaag, D. J. Veltman, L. Lu, M. Aghajani, G. van Wingen, Hippocampal, thalamic, and amygdala subfield morphology in major depressive disorder: an ultra-high resolution MRI study at 7-Tesla. Eur. Arch. Psychiatry Clin. Neurosci., doi: 10.1007/s00406-024-01874-0 (2024).

C. Wang, X. Lan, W. Liu, Y. Zhan, W. Zheng, X. Chen, G. Liu, S. Mai, H. Lu, R. S. McIntyre, Y. Zhou, Y. Ning, Non-improvement predicts subsequent non-response to repeated-dose intravenous ketamine for depression: a re-analysis of a 2-week open-label study in patients with unipolar and bipolar depression. Transl. Psychiatry 14, 1–11 (2024).

Y. Zhao, Q. Liang, Z. Jiang, H. Mei, N. Zeng, S. Su, S. Wu, Y. Ge, P. Li, X. Lin, K. Yuan, L. Shi, W. Yan, X. Liu, J. Sun, W. Liu, G. van Wingen, Y. Gao, Y. Tan, Y. Hong, Y. Lu, P. Wu, X. Zhang, Y. Wang, J. Shi, Y. Wang, L. Lu, X. Li, Y. Bao, Brain abnormalities in survivors of COVID-19 after 2-year recovery: a functional MRI study. Lancet Reg. Health – West. Pac. 47 (2024).

S. Li*, W. Liu*, Z. Huang, H. Lin, Y. Ning, Z. Li, Sex-specific associations between sex hormones and clinical symptoms in late-life schizophrenia. Schizophr. Res. 267, 1–7 (2024).

W. Liu*, H. Li*, X. Lin*, P. Li, X. Zhu, S. Su, J. Shi, L. Lu, J. Deng, X. Sun, Blunted superior temporal gyrus activity to negative emotional expression after mindfulness-based cognitive therapy for late-life depression. Front. Aging Neurosci. 14, 1001447 (2022).

K. Yuan, Y. Zheng, Y. Wang, Y. Sun, Y. Gong, Y. Huang, X. Chen, X. Liu, Y. Zhong, S.Su, N. Gao, Y. Lu, Z. Wang, W. Liu, J. Que, Y. Yang, A. Zhang, M. Jing, C. Yuan, N. Zeng, M. V Vitiello, V. Patel, S. Fazel, H. Minas, G. Thornicroft, T. Fan, X. Lin, W. Yan, L. Shi, J. Shi, T.Kosten, Y. Bao, L. Lu, A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. Mol. Psychiatry 27, 3214–3222 (2022).

M. Wang, X. Chen, Y. Hu, Y. Zhou, C. Wang, W. Zheng, W. Liu, X. Lan, Y. Ning, B. Zhang, Functional connectivity between the habenula and default mode network and its association with the antidepressant effect of ketamine. Depress. Anxiety 39, 352–362 (2022).

W. Li, Y. Zhou, W. Liu, C. Wang, X. Lan, Z. Zhang, F. Zhang, Y. Ye, H. Liu, K. Wu, R. S. McIntyre, Y. Ning, Long-term outcomes of repeated ketamine infusions in patients with unipolar and bipolar depression: A naturalistic follow-up study. J. Affect. Disord. 300, 172–178 (2022).

J. Sun, Y. Zheng, L. Liu, S. Li, Y. Zhao, X. Zhu, J. Que, M. Li, W. Liu, K. Yuan, W. Yan, X. Liu,S. Chang,X. Chen, N. Gao, J. Shi, Y. Bao, L. Lu, The Impact of Quarantine on Pain Sensation among the General Population in China during the COVID-19 Pandemic. Brain Sci. 12, 79 (2022).

C. Yang*, W. Liu*, Y. Chen, J. Zhang, X. Zhong, Q. Du, J. Zhang, J. Mo, Z. Chen, Y. Ning, Prevalence and risk factors for mental health symptoms in community epidemic prevention workers during the postpandemic era of COVID-19 in China. Psychiatry Res. 304, 114132 (2021).

Y. Han, K. Yuan, Z. Wang, W. Liu, Z. Lu, L. Liu, L. Shi, W. Yan, J. Yuan, J. Li, J. Shi, Z. Liu, G. Wang, T.Kosten, Y. Bao, L. Lu, Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions. Transl. Psychiatry 11, 499 (2021).

L. Shi, Z. Lu, J. Que, X. Huang, Q. Lu, L. Liu, Y. Zheng, W. Liu, M. Ran, K. Yuan, W. Yan, Y. Sun, S. Sun, J. Shi, T.Kosten, Y. Bao, L. Lu, Long-term impact of COVID-19 on mental health among the general public: a nationwide longitudinal study in China. Int. J. Environ. Res. Public. Health 18, 8790 (2021).

M. Wang, B. Zhang, Y. Zhou, C. Wang, W. Zheng, W. Liu, Y. Zhan, X. Lan, Y. Ning, Sleep improvement is associated with the antidepressant efficacy of repeated-dose ketamine and serum BDNF levels: a post-hoc analysis. Pharmacol. Rep. 73, 594–603 (2021).

X. Chen, M. Wang, Y. Hu, Y. Zhan, Y. Zhou, W. Zheng, W. Liu, C. Wang, X. Zhong, H. Li, X. Lan, Y. Ning, B. Zhang, Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 271, 431–438 (2021).

Y. Zhou, W. Liu, C. Wang, W. Zheng, X. Lan, S. Weng, Y. Ning, Cardiovascular effects of repeated subanaesthetic ketamine infusion in depression. J. Psychopharmacol. (Oxf.) 35, 159–167 (2021).

W. Zheng, Y. Zhou, W. Liu, C. Wang, Y. Zhan, X. Lan, B. Zhang, Y. Ning, A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression. J. Affect. Disord. 275, 38–43 (2020).

Y. Zhou, F. Wu, W. Liu, W. Zheng, C. Wang, Y. Zhan, X. Lan, Y. Ning, Volumetric changes in subcortical structures following repeated ketamine treatment in patients with major depressive disorder: a longitudinal analysis. Transl. Psychiatry 10, 264 (2020).

Y. Zhan, Y. Zhou, W. Zheng, W. Liu, C. Wang, X. Lan, X. Deng, Y. Xu, B. Zhang, Y. Ning, Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder. Transl. Psychiatry 10, 246 (2020).

X. Lan, Y. Zhou, W. Zheng, Y. Zhan, W. Liu, C. Wang, M. Jiang, M. Yu, B. Zhang, Y. Ning, Association between cognition and suicidal ideation in patients with major depressive disorder: a longitudinal study. J. Affect. Disord. 272, 146–151 (2020).

W. Liu, Y. Zhou, C. Wang, W. Zheng, Y. Zhan, X. Lan, B. Zhang, H. Li, L. Chen, M. Li, Baseline insomnia as a predictor of antidepressant efficacy to repeated intravenous ketamine for unipolar and bipolar depression: a preliminary study. J. Affect. Disord. 271, 1–8 (2020).

Y. Zhou, W. Liu, W. Zheng, C. Wang, Y. Zhan, X. Lan, B. Zhang, C. Zhang, Y. Ning, Predictors of response to repeated ketamine infusions in depression with suicidal ideation: an ROC curve analysis. J. Affect. Disord. 264, 263–271 (2020).

W. Zheng, X. Li, Z. Shi, X. Yang, D. Cai, C. H. Ng, G. S. Ungvari, W. Liu, Y. Wu, Y. Wang, Y. Ning, Y. Xiang, Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials. Pharmacopsychiatry 53, 5–13 (2020).

W. Liu, Y. Zhou, W. Zheng, C. Wang, Y. Zhan, X. Lan, B. Zhang, H. Li, L. Chen, Y. Ning, Repeated intravenous infusions of ketamine: neurocognition in patients with anxious and nonanxious treatment-resistant depression. J. Affect. Disord. 259, 1–6 (2019).

C. Wang, Y. Zhou, W. Zheng, W. Liu, Y. Zhan, H. Li, L. Chen, B. Zhang, M. Walter, M. Li, M. D. Li, Y. Ning, Association between depression subtypes and response to repeated‐dose intravenous ketamine. Acta Psychiatr. Scand. 140, 446–457 (2019).

Y. Zhan, B. Zhang, Y. Zhou, W. Zheng, W. Liu, C. Wang, H. Li, L. Chen, L. Yu, M. Walter, A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation. J. Affect. Disord. 251, 205–212 (2019).

W. Zheng, Y. Zhou, W. Liu, C. Wang, Y. Zhan, H. Li, L. Chen, M. Li, Y. Ning, Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder. J. Psychopharmacol. (Oxf.) 33, 494–501 (2019).

W. Liu, Y. Zhou, W. Zheng, C. Wang, Y. Zhan, H. Li, L. Chen, C. Zhao, Y. Ning, Mediating effect of neurocognition between severity of symptoms and social-occupational function in anxious depression. J. Affect. Disord. 246, 667–673 (2019).

W. Zheng, Y. Zhou, W. Liu, C. Wang, Y. Zhan, H. Li, L. Chen, M. Li, Y. Ning, Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder. J. Affect. Disord. 246, 241–247 (2019).

Y. Zhou, W. Zheng, W. Liu, C. Wang, Y. Zhan, H. Li, L. Chen, Y. Ning, Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder. Psychoneuroendocrinology 101, 72–79 (2019).

Y. Zhou, W. Zheng, W. Liu, C. Wang, Y. Zhan, H. Li, L. Chen, M. Li, Y. Ning, Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression. Brain. Behav. Immun. 74, 205–212 (2018).

W. Zheng, Y. Zhou, W. Liu, C. Wang, Y. Zhan, H. Li, L. Chen, M. Li, Y. Ning, Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. J. Psychiatr. Res. 106, 61–68 (2018).

Y. Zhou, W. Zheng, W. Liu, C. Wang, Y. Zhan, H. Li, L. Chen, M. Li, Y. Ning, Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression. J. Psychopharmacol. (Oxf.) 32, 1118–1126 (2018).